Efficacy And Safety Of Travoprost Versus Timolol To Treat Early-Onset Ocular Hypertension Secondary To Vitrectomy: A Randomized Trial

PURPOSE: To evaluate the efficacy and safety of travoprost 0.004% versus timolol 0.5% as an initial intraocular pressure (IOP)-lowering medication for ocular hypertension secondary to vitrectomy. PATIENTS AND METHODS: We performed a randomized, controlled, observer-blinded clinical trial in the Eye...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yuan, Ku, Hsiangyu, Gan, Dekang, Jiang, Rui, Sun, Xinghuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777640/
https://www.ncbi.nlm.nih.gov/pubmed/31686785
http://dx.doi.org/10.2147/DDDT.S222796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777640/
https://www.ncbi.nlm.nih.gov/pubmed/31686785
http://dx.doi.org/10.2147/DDDT.S222796

Ejemplares similares